Groot, J. d., Ott, M., Wei, J., Kassab, C., Fang, D., Najem, H., . . . Heimberger, A. B. A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma. Taylor & Francis Group.
Chicago Style (17th ed.) CitationGroot, John de, et al. A First-in-human Phase I Trial of the Oral P-STAT3 Inhibitor WP1066 in Patients with Recurrent Malignant Glioma. Taylor & Francis Group.
MLA (9th ed.) CitationGroot, John de, et al. A First-in-human Phase I Trial of the Oral P-STAT3 Inhibitor WP1066 in Patients with Recurrent Malignant Glioma. Taylor & Francis Group.
Warning: These citations may not always be 100% accurate.